Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				NIOSH Reports to Congress						Print
																Related Pages
										On This Page
			Information GatheringSpecial Exposure Cohort (SEC)Residual Contamination
		
Access to Information for Dose Reconstruction
Section 3134(a) of the National Defense Authorization Act for Fiscal Year 2004 required that NIOSH submit a report on its ability to obtain the information necessary to complete radiation dose reconstructions.
NIOSH responded in its May 5, 2004, report to Congress. The report describes the information needed for dose reconstructions. It also explains what can hinder us from getting information in a timely, accurate, and complete manner.
Report to Congress: Access to Information for Performance of Radiation Dose Reconstructions [196 KB (18 pages)] (May 5, 2004)  
Attachment 1: Dose Reconstruction Processing Timeline Goals (May 5, 2004) [51 KB (1 page)]
Attachment 2: Dose Reconstruction Cases by Nuclear Weapons Production Facility [82 KB (5 pages)]Special Exposure Cohort (SEC)
SEC Cancers
The Act refers to 22 “specified cancers” under the Special Exposure Cohort. In response to a 2005 report by the Senate (S. Rep. 109-103), NIOSH investigated 11 other cancers for possible inclusion in the list. Our researchers looked for evidence that these 11 “non-presumptive cancers” (cancers not presumed to be caused by radiation exposure) were in fact radiogenic (caused by radiation exposure). We issued conclusions in an interim report in June 2007 but continued research on the topic. We issued a final report in 2009 on the basis of several new reviews. One of these was a major review of the radiogenicity of specific cancers (by the United Nations Scientific Committee on the Effects of Atomic Radiation), and two others served as primary references for the final NIOSH report. None of this research, however, led us to change the conclusions we had presented in the 2007 interim report.
NIOSH still found consistent evidence in the reviews to support the radiogenicity of basal cell carcinoma. The final report lists the number of cases of basal cell carcinoma among the classes of employees included in the Special Exposure Cohort (SEC), as requested by the Senate in 2005.
Interim Report
Report to the Senate Appropriations Committee on the Radiogenicity of Specific Cancers under the Energy Employees Occupational Illness Compensation Program Act of 2000 as Amended [30 KB (11 pages)] (June 2007)Final Report
Report to the Senate Appropriations Committee on The Radiogenicity of Specific Cancers Under the Energy Employees Occupational Illness Compensation Program Act of 2000 as Amended [53 KB (10 pages)] (December 2009)Special Exposure Cohort Petition Status
This report responds to Section 3167(b) of the Ronald W. Reagan National Defense Authorization (NDAA) Act for Fiscal year 2005, Public Law 108-375. This Act required that NIOSH provide a status report on Special Exposure Cohort petitions that were filed before October 1, 2004.
The report includes the following:
Summary of the procedures for designating classes of employees as members of the SEC
Information on the current status of each petition at the time of the report
Estimate of the time needed to complete the consideration of each petition
Discussion of actions or circumstances that could prevent the Advisory Board on Radiation and Worker Health from acting upon a petition before the end of Fiscal Year 2005 (September 30, 2005)Report to Congress: Status of Petitions for Designating Classes of Employees as Members of the Special Exposure Cohort [427 KB (12 pages)] (September 2005)
Residual Radioactive and Beryllium Contamination
The National Defense Authorization Act for Fiscal Year 2002 (Pub. L. 107-107; Section 3151(b)) required that NIOSH submit, with the cooperation of the Department of Labor and Department of Energy, a report on whether or not significant contamination remained in any atomic weapons employer facility or facility of a beryllium vendor after the facility discontinued nuclear weapon production activities.
NIOSH issued the original “Report on Residual Radioactive and Beryllium Contamination at Atomic Weapons Employer Facilities and Beryllium Vendor Facilities” in November 2002 and updated it in October 2003. The Ronald W. Reagan National Defense Authorization Act for Fiscal Year 2005 (Pub. L. 108-375; Section 3169) required that NIOSH submit an additional update to the report in December 2006. Further updates were issued by NIOSH in October 2009 and August 2011.
More information on the report can be found on the Frequently Asked Questions (FAQs) Residual Contamination Report page of our website.
The most recent and previous versions of the report are listed below:
Latest Version of the Residual Contamination Report
August 2011 Report [59 KB (10 pages)] 
Appendix A-1 [98 KB (7 pages)]
Appendix A-2 [838 KB (233 pages)]
Appendix B-1 [44 KB (3 pages)]
Appendix B-2 [352 KB (100 pages)]Previous Versions of the Residual Contamination Report
October 2009 Report [44 KB (8 pages)] 
Appendix A-1 [133 KB (13 pages)]
Appendix A-2 [741 KB (239 pages)]
Appendix B-1 [57 KB (5 pages)]
Appendix B-2 [304 KB (100 pages)]
December 2006 Report [2.3 MB (9 pages)] 
Appendix A-1 [30 KB (12 pages)]
Appendix A-2 [46 KB (14 pages)]
Appendix A-3 [536 KB (236 pages)]
Appendix B-1 [22 KB (4 pages)]
Appendix B-2 [23 KB (4 pages)]
Appendix B-3 [237 KB (96 pages)]
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue